Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 322
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06113640 Montelukast in Parkinson Disease |
levodopa-carbidopa | Parkinson | Phase 2/3 | COMPLETED | En attente / non publié | Mostafa Bahaa | Egypt · Faculty of Medicine, Tanta University, Tanta,… | 2023-11-05 → 2026-08-20 | Ouvrir |
| NCT02880033 LymphoEnergy — Oxidative Stress and Apoptosis of Energy Metabolism by D… |
deferiprone | Sclérose latérale amyotrophique | Non applicable | COMPLETED | En attente / non publié | University Hospital, Lille | France · Hôpital Roger Salengro, CHRU de Lille, Lille… | 2011-02 → 2020-03 | Ouvrir |
| NCT00461942 Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Dise… |
Green Tea Polyphenols (EGCG/ECG) | Parkinson | Phase 2 | COMPLETED | En attente / non publié | Xuanwu Hospital, Beijing | China · Beijing Institute of Geriatrics, Xuanwu Hospi… | 2006-04 → 2009-03 | Ouvrir |
| NCT07838636 EPA-DBS — Effect of Physical Activity on the Course of Parkinson's Dise… |
Physiotherapy | Parkinson | Non applicable | RECRUITING | En attente / non publié | Medical University of Warsaw | Poland · Department of Neurology, Faculty of Health S… | 2024-09-05 → 2028-09-05 | Ouvrir |
| NCT05152147 HERIZON-GEA-01 — A Study of Zanidatamab in Combination With Chemotherap… |
Zanidatamab | Parkinson | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Jazz Pharmaceuticals | Argentina, Australia, Belgium, Brazil, Canada, Chile,… | 2021-12-02 → 2027-09-30 | Ouvrir |
| NCT07840027 Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-0… |
TRB-001 | Parkinson | Phase 1 | RECRUITING | En attente / non publié | Tridem Bioscience FlexCo | Austria · PROSENEX Studienzentrum an der ATOMOS Klini… | 2026-09 → 2028-09 | Ouvrir |
| NCT07839793 FLORA — A 12-Week Study of Flexilev With the OraFID Device and App in P… |
OraFID dosing device, Levodopa/Ca… | Parkinson | Phase 4 | RECRUITING | En attente / non publié | Navamedic AB | Sweden · Centrum för Neurologi, Stockholm, Sweden | K… | 2026-05-25 → 2027-06-30 | Ouvrir |
| NCT06891781 ADVENT — Investigating Adaptive Deep Brain Stimulation in Parkinson's D… |
Deep Brain Stimulation | Parkinson | Non applicable | RECRUITING | En attente / non publié | Boston Scientific Corporation | Italy · IRCCS San Gerardo dei Tintori, Monza, Italy | 2026-08-26 → 2029-08 | Ouvrir |
| NCT07839481 tcVNS-PD — Effects of Transcutaneous Cervical Vagus Nerve Stimulation o… |
transcutaneous vagus nerve stimul… | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Kyoungwon Baik | Non communiqué | 2026-09-30 → 2027-06-30 | Ouvrir |
| NCT04626518 Substudy 03B: A Study of Immune and Targeted Combination Therapies in P… |
Pembrolizumab | Parkinson | Phase 1/2 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Canada, Chile, France, Hung… | 2020-12-17 → 2026-07-23 | Ouvrir |
| NCT04626479 Substudy 03A: A Study of Immune and Targeted Combination Therapies in P… |
Pembrolizumab | Parkinson | Phase 1/2 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Canada, Chile, Colombia, Fr… | 2020-12-16 → 2026-08-10 | Ouvrir |
| NCT07569133 Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving … |
Repetitive Transcranial Magnetic … | Parkinson | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Chi-Ying (Roy) Lin | South Korea · Kyungpook National University Chilgok h… | 2026-05-04 → 2026-12-31 | Ouvrir |
| NCT05164783 EPD — Multicenter Implementation of E-monitoring in Parkinson's Disease |
Sanacoach Parkinson (SCP) | Parkinson | Non applicable | COMPLETED | En attente / non publié | Zuyderland Medisch Centrum | Netherlands · Elkerliek Hospital, Helmond, Netherland… | 2021-11-23 → 2025-07-27 | Ouvrir |
| NCT06466525 A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tole… |
LBT-3627 | Parkinson | Phase 1 | RECRUITING | En attente / non publié | Longevity Biotech Australia Pty L… | Australia · Alfred Hospital, Melbourne, Australia | M… | 2024-07-16 → 2027-02 | Ouvrir |
| NCT07842302 NIBS_MSf — Fighting Fatigue in Multiple Sclerosis: TMS vs. tDCS Efficac… |
TMS | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Universitat Oberta de Catalunya | Non communiqué | 2026-09 → 2029-09 | Ouvrir |
| NCT06498687 Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia |
CYR-064 | SEP | Phase 1 | WITHDRAWN | En attente / non publié | University of Nebraska | Non communiqué | 2025-04 → 2026-07 | Ouvrir |
| NCT04738487 Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembroliz… |
pembrolizumab/vibostolimab | Parkinson | Phase 3 | TERMINATED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Brazil, Canada, Chile, China, Dominica… | 2021-04-07 → 2026-01-27 | Ouvrir |
| NCT04634877 Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemother… |
Pembrolizumab | Parkinson | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Austria, Belgium, Canada, C… | 2021-01-10 → 2026-11-20 | Ouvrir |
| NCT07592767 RESvEraTrol in Parkinson's Disease (RESET) |
Trans-Resveratrol | Parkinson | Phase 2 | RECRUITING | En attente / non publié | Georgetown University | United States · Georgetown University Hospital, Washi… | 2026-09-17 → 2029-06-01 | Ouvrir |
| NCT07827456 MRI-Guided Temporal Interference Stimulation for Parkinson's Disease |
Temporal Interference Stimulation… | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Tongji Hospital | Non communiqué | 2026-09-15 → 2027-06-10 | Ouvrir |
| NCT07056361 Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve … |
Direct cortical stimulation and d… | Parkinson | Non applicable | RECRUITING | En attente / non publié | Jorge Gonzalez-Martinez | United States · University of Pittsburgh, Pittsburgh,… | 2022-12-16 → 2030-12-31 | Ouvrir |
| NCT01019343 Physiological Investigations of Movement Disorders |
Transcranial Direct Current Stimu… | Parkinson | Non applicable | COMPLETED | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2009-12-08 → 2020-10-09 | Ouvrir |
| NCT07738107 ATR 1072 in Participants With PRKAG2 Syndrome |
ATR 1072 | Parkinson | Phase 1/2 | RECRUITING | En attente / non publié | Atrium Therapeutics | United States · St Luke's Mid American Heart Institut… | 2026-09-14 → 2028-10 | Ouvrir |
| NCT04127578 Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkins… |
LY3884961 | Parkinson | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Prevail Therapeutics | United States, Israel · Esperanza Clinical, 25220 Han… | 2020-01-03 → 2031-08-31 | Ouvrir |
| NCT05101161 Neurofeedback Using Implanted Deep Brain Stimulation Electrodes |
Neurofeedback Using Implanted Dee… | Épilepsie | Non applicable | RECRUITING | En attente / non publié | ETH Zurich | Switzerland · ETH Zurich, Zurich, Switzerland | 2021-09-23 → 2028-09-23 | Ouvrir |